Earle A. Chiles Research Institute

Advancements in treatment and early detection have improved survival for women diagnosed with breast cancer. For patients with locally advanced or metastatic breast cancer, better therapies are needed

Investigators present latest research in cancer immunotherapy, receive noteworthy awards, at the 35th annual meeting of the Society for Immunotherapy of Cancer.

Providence researchers launch COVID-19 vaccine clinical trial designed for older adults.

Providence Cancer Institute is one of the few highly specialized centers offering adoptive cellular therapy for hematologic malignancies. Chimeric antigen receptor (CAR) T-cell therapy is a revolution

Providence Cancer Institute joins oncology professionals around the world for ESMO Virtual Congress 2020, the annual meeting of the European Society for Medical Oncology, held online from September 14

The incidence of melanoma is increasing faster than other skin cancers. Although surgery can cure early stage melanomas, and many new standard therapies for advanced disease improve survival, few are

Providence Cancer Institute is the first facility in the Pacific Northwest, and the first community medical center in the country, to offer MRI-guided radiation therapy for patients with pancreatic ca

An unmet clinical need exists for patients with cancers associated with human papillomavirus. A new phase I study at Providence Cancer Institute will evaluate a novel biologic therapy in patients with

The outbreak of coronavirus disease 2019 (COVID-19) brought about an unprecedented global threat to public health. Providence has been at the forefront of COVID-19 treatment and research in the United

Researchers at the Earle A. Chiles Research Institute, a division of Providence Cancer Institute in Portland, Oregon, will join oncology professionals around the world for the 2020 ASCO Virtual Scient